Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Sells $345,400.00 in Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Director Lori Anne Kunkel sold 10,000 shares of the business’s stock in a transaction on Friday, June 5th. The shares were sold at an average price of $34.54, for a total transaction of $345,400.00. Following the completion of the sale, the director directly owned 51,884 shares in the company, valued at $1,792,073.36. This represents a 16.16% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bitwise MARA Option Income Strategy ETF Stock Down 0.8%

IMRA traded down $0.13 during trading on Tuesday, hitting $16.58. The company had a trading volume of 3,866 shares, compared to its average volume of 5,447. The company has a market capitalization of $3.15 million, a PE ratio of 331.60 and a beta of 2.88. Bitwise MARA Option Income Strategy ETF has a one year low of $11.99 and a one year high of $54.94. The firm’s 50-day moving average price is $15.80 and its 200 day moving average price is $15.97.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.